![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Journal of Virology, December 1998, p. 10310-10315, Vol. 72, No. 12
Plum Island Animal Disease Center,
Agricultural Research Service, U.S. Department of Agriculture,
Greenport, New York 11944-0848
Received 15 July 1998/Accepted 2 September 1998
African swine fever virus (ASFV) replicates in the cytoplasm of
infected cells and contains genes encoding a number of enzymes needed
for DNA synthesis, including a thymidine kinase (TK) gene. Recombinant
TK gene deletion viruses were produced by using two highly pathogenic
isolates of ASFV through homologous recombination with an ASFV p72
promoter- African swine fever virus (ASFV) is
a large icosahedral enveloped DNA virus and is classified as the only
member of a new virus family, the Asfaviridae (3,
11). The structure and replication of its 170- to 190-kbp genome
are similar to those of the poxviruses, but the icosahedral morphology
of the virus more closely resembles that of the iridoviruses (for
reviews see references 9, 43, and
44). African swine fever (ASF) is recognized as an
important disease of domestic swine and is characterized by high
fevers, hemorrhage, shock, and 100% mortality for highly pathogenic
isolates. ASF may range from an acute, highly lethal infection to a
subclinical form, depending on contributing viral and host factors. The
virus infects cells of the mononuclear-phagocytic system, including
highly differentiated fixed-tissue macrophages and specific lineages of
reticular cells in the spleen, lymph node, lung, kidney, and liver.
These tissues show extensive damage with highly virulent strains of
ASFV, and the ability of ASFV to replicate and induce cytopathology in
these tissues in vivo appears to be a critical factor in ASFV virulence
(8, 24, 25, 30, 32). The nature of viral factors responsible
for the virulence and pathogenesis of ASFV remains poorly understood.
Like poxviruses and iridoviruses, ASFV replicates in the cytoplasm and
encodes enzymes for transcription and DNA synthesis (17,
46), since enzymes of the host cell nucleus are unavailable. Also, ASFV encodes enzymes involved in synthesis of deoxynucleoside triphosphates: the thymidine kinase (TK) enzyme (1, 28, 38), the ribonucleotide reductase (RR) enzyme (2, 10), and the thymidylate kinase (TMPK) enzyme (47). These enzymes are
also encoded by other large DNA viruses (29). Herpesviruses
encode a single polypeptide with both TK and TMPK activities
(39). These enzymes are involved in the salvage and de novo
pathways of dTTP synthesis. The ASFV TK gene has been shown to be
nonessential for the growth of ASFV in cultured hamster and monkey
cells (27, 40).
The inactivation of the TK gene in poxviruses and herpesviruses showed
the gene to be nonessential for growth in cultured cells (12, 21,
26, 36), but TK In this study, we have constructed TK gene deletion mutants of
pathogenic ASFV isolates in order to examine the role of this gene in
viral pathogenesis and virulence. Experiments using primary swine
macrophages failed to produce stable TK deletion mutants, suggesting
that the ASFV TK gene might be important for viral replication in this
cell type (31). Two pathogenic ASFV isolates, partially
adapted to Vero cells, were used successfully to construct TK deletion
viruses on Vero cells. The loss of TK from these viruses impaired their
growth on swine macrophages in vitro and reduced their virulence in
vivo. Thus, TK could be considered an important gene for growth in
target macrophage cells and possibly in other tissues involved in the
pathogenesis of lethal ASFV infections.
Construction of recombinant ASFV TK gene deletion mutants and
TK-positive revertants.
The pathogenic tissue culture-adapted ASFV
Malawi LiL-20/1V (Vero Malawi) and ASFV Haiti H811 (H811) were obtained
from the Plum Island Animal Disease Center ASFV reference collection
and grown on Vero cells, and viral DNA was obtained (45).
ASFV recombinant viruses were generated by homologous recombination
between parental ASFV genomes and engineered recombination vectors as
previously described (34, 48), except that Vero cells were
used for transfection/infection and isolation of
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The African Swine Fever Virus Thymidine Kinase Gene Is Required
for Efficient Replication in Swine Macrophages and for Virulence
in Swine
ABSTRACT
Top
Abstract
Text
References
-glucuronidase indicator cassette (p72GUS) flanked by ASFV
sequences targeting the TK region. Attempts to isolate double-crossover
TK gene deletion mutants on swine macrophages failed, suggesting a
growth deficiency of TK
ASFV on macrophages. Two
pathogenic ASFV isolates, ASFV Malawi and ASFV Haiti, partially adapted
to Vero cells, were used successfully to construct TK deletion viruses
on Vero cells. The selected viruses grew well on Vero cells, but both
mutants exhibited a growth defect on swine macrophages at low
multiplicities of infection (MOI), yielding 0.1 to 1.0% of wild-type
levels. At high MOI, the macrophage growth defect was not apparent. The
Malawi TK deletion mutant showed reduced virulence for swine, producing
transient fevers, lower viremia titers, and reduced mortality. In
contrast, 100% mortality was observed for swine inoculated with the
TK+ revertant virus. Swine surviving TK ASFV
infection remained free of clinical signs of African swine fever
following subsequent challenge with the parental pathogenic ASFV. The
data indicate that the TK gene of ASFV is important for growth in swine
macrophages in vitro and is a virus virulence factor in swine.
TEXT
Top
Abstract
Text
References
viruses exhibited a reduction in
virulence and pathogenicity in experimental animal hosts. A
104 to 105 reduction in the 50% lethal dose
(LD50) was noted for mice injected with TK
vaccinia or ectromelia virus (4, 23), and TK
herpes simplex virus and marmoset herpesvirus showed similar losses of
virulence in mice (13, 22). Cell culture conditions were
found to be important, as serum-starved cultures showed reduced growth
of TK, but not of TK+, herpesviruses
(13, 21). Also, TK herpes simplex virus showed
a reduced ability to infect highly differentiated neuronal tissues
(13, 42). In similar fashion, highly differentiated murine
macrophages, an important type of target cell in the pathogenesis of
ectromelia virus infection in mice, failed to support the growth of
TK ectromelia virus (23).
-glucuronidase
(GUS)-positive virus foci. The exchange vector (p5.3) was produced by
the sequential cloning into plasmid pBluescript II KS (Stratagene) of
PCR-derived DNA of left (892 bp) and right (956 bp) TK flanking
sequences, deleting the central region of the TK gene (315 bp; codons
55 to 158) but leaving the N-terminal and C-terminal TK coding regions
intact and inserting a 2.4-kb reporter cassette (p72GUS) consisting of the ASFV p72 gene promoter linked to the GUS gene (34) (Fig. 1). GUS-positive foci were picked from
agarose overlays containing 100 µg of
5-bromo-4-chloro-3-indolyl--D-glucuronic acid (X-Gluc) per ml (48) and were plaque purified four to six times until PCR and Southern blot analysis (41) showed no evidence of
contamination with the parental virus.
View larger version (29K):
[in a new window]
FIG. 1.
Diagram of the TK region of the Malawi LiL-20/1 genome,
showing the placement and orientation of the TK gene and adjacent genes
p10 (DNA binding protein 5-AR) (33), K205R, K145R, and K421R
(Ba71V open reading frames) (46); structure of the TK gene
deletion transfer vector, p5.3, showing insertion sites into the
pBluescript multiple cloning site; and structure of plasmid pLR-TK,
containing a 2,164-bp PCR fragment of the intact TK gene and flanking
ASFV DNA.
|
recombinant
viruses on macrophages and initial growth analysis of ASFV recombinant v5.3 on macrophages suggested a growth deficiency in macrophages. Therefore, a positive growth selection method was attempted in order to
rescue TK+ revertants. A 2,164-bp fragment spanning the TK
gene was amplified by using the left flank 5'-forward and the right
flank 3'-reverse primer (described above) to construct the TK knockout
vector and cloned into pBluescript, resulting in plasmid pLR-TK. This
plasmid contained the complete TK gene with 734 bp of ASFV TK-flanking sequences upstream and 865 bp downstream (Fig. 1). Swine macrophage cultures (16, 34) were infected with ASFV v5.3, transfected with plasmid pLR-TK, blind passaged three times on swine macrophages, and purified by endpoint dilution, resulting in virus v5.3R. Virus stocks were made on swine macrophages, and viral DNA was prepared. Southern blot analysis showed the presence of the native 3.0-kb TK
fragment and no reactivity with the GUS probe (Fig. 2A and B, lanes 4),
indicating restoration of the native TK genotype.
TK is important for in vitro growth of ASFV on porcine macrophages. Growth properties of the Malawi (v5.3) and Haiti (vH53) TK deletion mutants were compared to those of the respective parental Vero-adapted viruses on swine macrophage and Vero cell cultures. At a low multiplicity of infection (MOI = 0.01), the parental isolates grew well on both Vero and macrophage cultures (data not shown). The TK deletion mutants grew well on Vero cells (data not shown) but grew poorly on macrophages; Malawi v5.3 and Haiti vH53 grew to 0.1 and 1% of parental levels, respectively (Fig. 3A and B). However, at high MOIs (10 to 20), the growth defect of the TK deletion mutants was not apparent (Fig. 3C and D).
|
mutants.
|
|
mutant v5.3 grown on Vero cell and macrophage cultures
were examined by dot blot hybridization (41). Cells were
infected at MOIs of 1 to 2, DNA was isolated from cells at 24 h
postinfection (p.i.), and dilution sets of DNA were blotted onto Zeta
Probe membranes (Bio-Rad) and probed with a 32P-labelled
2,164-bp TK region DNA fragment (SalI/NotI-cut
DNA from pLR-TK). On macrophages, the parental ASFV Malawi consistently produced large amounts of viral DNA. For v5.3 no viral DNA was detected
in two experiments, and in a third, a small amount of v5.3 DNA was
present over background levels measured at 2 h p.i. In comparison,
both the Vero-adapted ASFV Malawi and the TK mutant v5.3
synthesized large amounts of viral DNA on Vero cells (data not shown).
Cellular levels of TK are very low in quiescent, nondividing cells but
increase dramatically during cell division (37), and TK
activity in primary macrophage cultures is very low, even during
prolonged incubation in complete growth medium (31). With
pools of nucleoside triphosphates low in macrophages, the loss of viral
TK activity might be expected to have a significant effect on viral DNA
synthesis and subsequent production of viral progeny. The TK, RR, and
TMPK enzymes have all been implicated in attenuation of poxviruses
(4, 7, 19) and herpesviruses (5, 20, 22). For
ASFV, the levels of expression of these enzymes in different isolates
of ASFV are not known, and each may contribute to viral replication in
quiescent cells such as macrophages. Here, in virus growth experiments,
the growth defect of the TK mutants was overcome at high MOIs. The
levels of RR found in ASFV-infected Vero cells were shown to be
proportional to the MOIs, and inhibition of DNA replication did not
alter the levels of RR present (10). Thus, early
transcription of RR at high MOIs could supplement the TK deficiency by
providing an alternate source of deoxythymidylate.
In the growth curve experiments, the TK deletion mutants grew poorly at
low MOIs compared to the parental viruses (Fig. 3A and B). However,
since there was some increase in virus titers over the first several
days, we cannot formally exclude the possibility that, after a single
round of replication, subsequent poor growth was due to failure of the
virus to be released and to infect adjacent cells. However, the nature
of growth defects of TK deletion mutants of other DNA viruses is linked
to nucleotide metabolism and subsequent viral DNA synthesis.
Furthermore, the passage experiments performed here showed that despite
harvest of virus from cell lysates and reapplication to new cells,
virus titers diminished (Fig. 4). The results of the growth experiments
and the diminished levels of DNA synthesized at low MOIs with v5.3
suggest that TK is important in macrophages for replication of viral
DNA in the cytoplasm of these cells.
TK affects ASFV virulence for swine.
To assess the importance
of the TK gene in viral virulence, two separate groups of four
Yorkshire pigs were inoculated intramuscularly with 104
50% tissue culture infective doses (TCID50) of the
revertant ASFV v5.3R or the TK mutant ASFV v5.3 and were
observed for clinical signs of ASF: fever, anorexia, lethargy,
shivering, cyanosis, and recumbency. A dose of 104
TCID50 of pathogenic ASFV strains represents a challenge of
1,000 to 10,000 LD100s (34, 48). Results of the
experiment are shown in Table 1. The
animals inoculated with the revertant virus showed signs typical of
acute ASF, with onset of fever at day 4 and all animals dying between
days 9 and 13. The swine inoculated with the mutant virus v5.3 showed
only transient fever responses, and one animal, which had the most
persistent fever, died at day 15. Except for transient fevers, the
remaining animals were clinically normal throughout the experiment.
Maximum viremia titers in the revertant virus group reached
106 to 107 TCID50, whereas the
titers for the mutant v5.3 group ranged from <103.5 to
106 TCID50, with viremia onset delayed 4 to 5 days. DNA from virus isolated at the peak of viremia from the
recombinant virus group was examined by PCR and found to be that of the
recombinant virus, with no wild-type virus DNA detected (data not
shown). By using a virus isolation-PCR-blot detection method
(6), virus was detected in only one animal of the ASFV v5.3
group at day 30 p.i. and none of the animals was positive at day
56 p.i. (data not shown). At day 56 p.i., the three surviving
v5.3-infected swine were challenged intramuscularly with
104 TCID50 of the parental Vero-adapted Malawi
virus. A fever response was noted in two of the three animals on days 4 to 6, and one animal remained febrile following this time. That animal
developed an infected abscess at the inoculation site which advanced to a severe cellulitis (the animal was sacrificed on day 21). Maximum viremia titers ranged from undetectable levels to levels lower than
104 TCID50/ml, and all animals remained free of
clinical symptoms for the experiment's duration.
|
ASFV v5.3 were
protected from developing ASF on virulent virus challenge. Recently,
another ASFV gene, 23-NL-S, was shown to be a virulence-associated gene
for ASF (48). However, ASFV 23-NL-S was nonessential for
growth in vitro in Vero cells and swine macrophages, but deletion of
the gene significantly reduced virulence for swine, suggesting that the
gene may serve as a host range gene in swine. Work with tissue
culture-adapted isolates of ASFV established that TK was nonessential
for growth in Vero cells (27, 40). However, the present
report shows the TK gene to be important for growth on macrophages in
vitro and to be a virulence factor in vivo. Thus, TK should be
considered an essential gene for the target lymphoreticular tissues
involved in the pathogenesis of lethal ASFV infections. However, it is
not known at this time if loss of the TK gene affects the ability of
the virus to infect lymphoreticular tissues and organs involved in the
pathogenesis of lethal ASF (8, 24, 25, 30, 32) or if a
reduction in virus load in swine may allow time for the development of
host defenses.
The TK locus has been used to demonstrate the feasibility of
constructing ASFV recombinant viruses (15, 27, 40), but these experiments used highly adapted, cell-cultured viruses no longer
virulent for swine, so the role of TK in the virulence and pathogenesis
of ASFV in swine could not be assessed. Several low-passage-number
isolates of ASFV retaining their infectivity for swine have been
engineered with chromogenic marker genes inserted into the TK locus,
and their use in tropism, pathogenicity, and latency studies has been
suggested (18). We have observed CPE, the expression of GUS
driven by an ASFV late gene promoter, and positive hemadsorption (late
expression of the CD2 gene) with TK deletion mutants in swine
macrophages, but the virus grows poorly and shows reduced virulence in
swine. The present work shows that the TK gene itself plays a
significant role in virus virulence and that this site would not be
suitable for the insertion of markers to monitor pathogenesis or as an
insertion site for other viral genes to assess their role in virus virulence.
We have demonstrated that the selective macrophage growth advantage of
TK+ ASFV may be used to engineer other ASFV gene deletions
through TK+ rescue of the ASFV mutant v5.3 (35).
Plasmids in which the intact TK gene with its upstream promoter
sequence replaced a specific gene of interest were engineered.
Preliminary experiments indicate that stable GUS+
TK+ recombinants which could be directly isolated through
selective growth on macrophage cultures were produced. These results
demonstrate the utility of using the TK gene as a selective factor in
genome manipulations of pathogenic isolates of ASFV and also confirm that the growth defect of ASFV v5.3 in macrophages was directly due to
the loss of the TK gene function.
Animals previously infected with the TK deletion mutant were resistant
to challenge with virulent ASFV Malawi, although the level of
attenuation of the TK deletion mutant would not render it suitable for
use as a vaccine. Better understanding of the role of TK, RR, and TMPK
enzymes in supplying pools of deoxynucleoside triphosphates for viral
DNA replication may define how these viral enzymes support the
replication of the virus in vivo. Modifications of the viral genes
controlling DNA metabolism in infected cells may be a valuable
component in the design of multiple-gene-deletion, attenuated live
virus vaccines for ASFV.
| |
ACKNOWLEDGMENTS |
|---|
We thank G. Kutish for assistance with sequence and statistical data analysis, T. Burrage for assistance in titration experiments, E. Kramer and R. Mireles for swine macrophage cell cultures, and the PIADC animal care staff for assistance with animal experiments.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Plum Island Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, P.O. Box 848, Greenport, NY 11944-0848. Phone: (516) 323-2500, ext. 306. Fax: (516) 323-2507. E-mail: dmoore{at}asrr.arsusda.gov.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. | Blasco, R., C. Lopez-Otin, M. Munoz, E.-O. Bockamp, C. Simon-Mateo, and E. Vinuela. 1990. Sequence and evolutionary relationships of African swine fever virus thymidine kinase. Virology 178:301-304[Medline]. |
| 2. | Boursnell, M., K. Shaw, R. J. Yanez, E. Vinuela, and L. Dixon. 1991. The sequences of the ribonucleotide reductase genes from African swine fever virus show considerable homology with those of the orthopoxvirus, vaccinia virus. Virology 184:411-416[Medline]. |
| 3. | Brown, F. 1986. The classification and nomenclature of viruses: summary of results of meetings of the International Committee on Taxonomy of Viruses in Sendai, September 1984. Intervirology 25:141-143. |
| 4. | Buller, R. M. L., G. L. Smith, K. Cremer, A. L. Notkins, and B. Moss. 1985. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 317:813-815[Medline]. |
| 5. |
Cameron, J. M.,
I. McDougall,
H. S. Marsden,
V. G. Preston,
D. M. Ryan, and J. H. Subak-Sharpe.
1988.
Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target.
J. Gen. Virol.
69:2607-2612 |
| 6. |
Carrillo, C.,
M. V. Borca,
C. L. Afonso,
D. V. Onisk, and D. L. Rock.
1994.
Long-term persistent infection of swine monocytes/macrophages with African swine fever virus.
J. Virol.
68:580-583 |
| 7. | Child, S. J., G. J. Palumbo, R. M. Buller, and D. E. Hruby. 1990. Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo. Virology 174:625-629[Medline]. |
| 8. | Colgrove, G. S., E. O. Haelterman, and L. Coggins. 1969. Pathogenesis of African swine fever in young pigs. Am. J. Vet. Res. 30:1343-1359[Medline]. |
| 9. | Costa, J. V. 1990. African swine fever virus, p. 247-270. In G. Darai (ed.), Molecular biology of iridoviruses. Kluwer Academic Publishers, Boston, Mass. |
| 10. | Cunha, C. V., and J. V. Costa. 1992. Induction of ribonucleotide reductase activity in cells infected with African swine fever virus. Virology 187:73-83[Medline]. |
| 11. | Dixon, L. K., D. L. Rock, and E. Vinuela. 1995. African swine fever-like viruses. Arch. Virol. 10(Suppl.):92-94. |
| 12. | Dubbs, D. R., and S. Kit. 1964. Mutant strains of herpes simplex deficient in thymidine kinase-inducing activity. Virology 22:493-502. |
| 13. | Field, H. J., and P. Wildy. 1978. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J. Hyg. Camb. 81:267-277. |
| 14. | Finney, D. J. 1984. Statistical methods in biological assays, 2nd ed., p. 524-533. Hafner Publishing Co., New York, N.Y. |
| 15. | Garcia, R., F. Almazan, J. M. Rodriguez, M. Alonso, E. Vinuela, and J. F. Rodriguez. 1995. Vectors for the genetic manipulation of African swine fever virus. J. Biotechnol. 40:121-131[Medline]. |
| 16. | Genovesi, E. V., F. Villinger, D. J. Gerstner, T. C. Whyard, and R. C. Knudsen. 1990. Effect of macrophage-specific colony-stimulating factor (CSF-1) on swine monocyte/macrophage susceptibility to in vivo infection by African swine fever virus. Vet. Microbiol. 25:153-176[Medline]. |
| 17. | Goebel, S. J., G. P. Johnson, M. E. Perkus, S. W. Davis, J. P. Winslow, and E. Paoletti. 1990. The complete DNA sequence of vaccinia virus. Virology 179:247-266[Medline]. |
| 18. | Gomez-Puertas, P., F. Rodriguez, A. Ortega, J. M. Oviedo, C. Alonso, and J. M. Escribano. 1995. Improvement of African swine fever virus neutralization assay using recombinant viruses expressing chromogenic marker genes. J. Virol. Methods 55:271-279[Medline]. |
| 19. |
Hughes, S. J.,
L. H. Johnston,
A. de Carlos, and G. L. Smith.
1991.
Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae.
J. Biol. Chem.
266:20103-20109 |
| 20. | Idowu, A. D., E. B. Fraser-Smith, K. L. Poffenberger, and R. C. Herman. 1992. Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo. Antivir. Res. 17:145-156[Medline]. |
| 21. |
Jamieson, A. T.,
G. A. Gentry, and J. H. Subak-Sharpe.
1974.
Induction of both thymidine and deoxycytidine kinase activity by herpes viruses.
J. Gen. Virol.
24:465-480 |
| 22. | Kit, S., H. Qavi, D. R. Dubbs, and H. Otsuka. 1983. Attenuated marmoset herpesvirus isolated from recombinants of virulent marmoset herpesvirus and hybrid plasmids. J. Med. Virol. 12:25-36[Medline]. |
| 23. | Kochneva, G. V., I. H. Urmanov, E. I. Ryabchikova, V. V. Streltsov, and O. I. Serpinsky. 1994. Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence. Virus Res. 34:49-61[Medline]. |
| 24. | Konno, S., W. D. Taylor, and A. H. Dardiri. 1971. Acute African swine fever. Proliferative phase in lymphoreticular tissue and the reticuloendothelial system. Cornell Vet. 61:71-84[Medline]. |
| 25. | Konno, S., W. D. Taylor, W. R. Hess, and W. P. Heuschele. 1971. Liver pathology in African swine fever. Cornell Vet. 61:125-150[Medline]. |
| 26. |
Mackett, M.,
G. L. Smith, and B. Moss.
1982.
Vaccinia virus: a selectable eukaryotic cloning and expression vector.
Proc. Natl. Acad. Sci. USA
79:7415-7419 |
| 27. | Martin Hernandez, A. M., A. Camacho, J. Prieto, A. M. Menendez del Campo, and E. Tabares. 1995. Isolation and characterization of TK-deficient mutants of African swine fever virus. Virus Res. 36:67-75[Medline]. |
| 28. |
Martin Hernandez, A. M., and E. Tabares.
1991.
Expression and characterization of the thymidine kinase gene of African swine fever virus.
J. Virol.
65:1046-1052 |
| 29. |
McGeoch, D. J.,
M. A. Dalrymple,
A. J. Davison,
A. Dolan,
M. C. Frame,
D. McNab,
L. J. Perry,
J. E. Scott, and P. Taylor.
1988.
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.
J. Gen. Virol.
69:1531-1574 |
| 30. | Mebus, C. A. 1988. African swine fever. Adv. Virus Res. 35:251-269[Medline]. |
| 31. | Moore, D. M. Unpublished data. |
| 32. | Moulton, J., and L. Coggins. 1968. Comparison of the lesions in acute and chronic African swine fever. Cornell Vet. 58:364-388[Medline]. |
| 33. |
Neilan, J. G.,
Z. Lu,
G. F. Kutish,
M. D. Sussman,
P. C. Roberts,
T. Yozawa, and D. L. Rock.
1993.
An African swine fever virus gene with similarity to bacterial DNA binding proteins, bacterial integration host factors, and the Bacillus phage SP01 transcription factor, TF1.
Nucleic Acids Res.
21:1496 |
| 34. | Neilan, J. G., Z. Lu, G. F. Kutish, L. Zsak, T. G. Burrage, M. V. Borca, C. Carrillo, and D. L. Rock. 1997. A BIR motif containing gene of African swine fever virus, 4CL, is nonessential for growth in vitro and viral virulence. Virology 230:252-264[Medline]. |
| 35. | Neilan, J. G., and D. M. Moore. 1997. Unpublished data. |
| 36. |
Panicali, D., and E. Paoletti.
1982.
Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
Proc. Natl. Acad. Sci. USA
79:4927-4931 |
| 37. | Pelka-Fleischer, R., W. Ruppelt, W. Wilmanns, H. Sauer, and A. Schalhorn. 1987. Relation between cell cycle stage and the activity of DNA-synthesizing enzymes in cultured human lymphoblasts: investigations on cell fractions enriched according to cell cycle stages by way of centrifugal elutriation. Leukemia 1:182-187[Medline]. |
| 38. | Polatnick, J., and W. Hess. 1970. Altered thymidine kinase activity in culture cells inoculated with African swine fever virus. Am. J. Vet. Res. 31:1609-1613[Medline]. |
| 39. |
Robertson, G. R., and J. M. Whalley.
1988.
Evolution of the herpes thymidine kinase: identification and comparison of the equine herpesvirus 1 thymidine kinase gene reveals similarity to a cell-encoded thymidylate kinase.
Nucleic Acids Res.
16:11303-11317 |
| 40. |
Rodriguez, J. M.,
F. Almazan,
E. Vinuela, and J. F. Rodriguez.
1992.
Genetic manipulation of African swine fever virus: construction of recombinant viruses expressing the -galactosidase gene.
Virology
188:67-76[Medline].
|
| 41. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 42. | Tenser, R. B., S. Rellel, and M. E. Dunstan. 1981. Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titer and evidence of in vivo complementation. Virology 112:328-341[Medline]. |
| 43. | Vinuela, E. 1985. African swine fever. Curr. Top. Microbiol. Immunol. 116:151-170[Medline]. |
| 44. | Vineula, E. 1987. Molecular biology of African swine fever virus, p. 31-49. In Y. Becker (ed.), Developments in veterinary virology. Martinus Nijhoff, Boston, Mass. |
| 45. | Wesley, R. D., and A. E. Tuthill. 1984. Genome relatedness among African swine fever virus field isolates by restriction endonuclease analysis. Prev. Vet. Med. 2:53-62. |
| 46. | Yanez, R. J., J. M. Rodriguez, M. L. Nogal, L. Yuste, C. Enriquez, J. F. Rodriguez, and E. Vinuela. 1995. Analysis of the complete nucleotide sequence of African swine fever virus. Virology 208:249-278[Medline]. |
| 47. |
Yanez, R. J.,
J. M. Rodriguez,
J. F. Rodriguez,
M. L. Salas, and E. Vinuela.
1993.
African swine fever virus thymidylate kinase gene: sequence and transcriptional mapping.
J. Gen. Virol.
74:1633-1638 |
| 48. | Zsak, L., Z. Lu, G. F. Kutish, J. G. Neilan, and D. L. Rock. 1996. An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene. J. Virol. 70:8865-8871[Abstract]. |
| 49. | Zsak, L., D. V. Onisk, C. L. Afonso, and D. L. Rock. 1993. Virulent African swine fever virus isolates are neutralized by swine immune serum and by monoclonal antibodies recognizing a 72-kDa viral protein. Virology 196:596-602[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|
